Health

Moderna to Pay About $1 Billion to Settle Arbutus Litigation

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts.
Photographer: Adam Glanzman/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Gerry Smith and Madison Muller

March 3, 2026 at 9:37 PM UTC

Updated on

March 4, 2026 at 2:49 PM UTC

Moderna Inc. agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing a looming financial risk for the struggling vaccine maker.

The company has settled all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH over its existing and future vaccines, with no future royalties owed.